Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
April 23, 2026
Calycia Bioscience was awarded the People’s Choice Award at the 2026 Altitude Labs Demo Day. CaLycia is developing engineered macrophage therapies that hone in on solid tumors and alleviate immune suppression, unlocking a broader immune response against some of the hardest targets in oncology. BioUtah congratulates Daniel Greiner and the Calycia Bioscience team!
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
